Analysts give Guardant Health, Inc. (NASDAQ:GH) a “Moderate Buy” rating on average.
According to Bloomberg, the fifteen research firms currently analyzing the company have given the stock of Guardant Health, INC (NASDAQ: ...
Tag: GH, Analyst Rating
Brokers Forecast Guardant Health, Inc. Earnings in Q1 2024 (NASDAQ:GH)
The anticipated monetary outcomes for the first three months of 2024 for Guardant Health, INC (NASDAQ: GH), as calculated by ...
Axa S.A. reduces its holdings in Guardant Health, Inc. (NASDAQ:GH).
The most recent 13F disclosure Axa S.A. submitted to the SEC revealed that the company had decreased its holdings in ...
Analysts have given Guardant Health, Inc. (NASDAQ:GH) a consensus recommendation of “Moderate Buy.”
Bloomberg.com reports that out of the 19 research firms that track the company and analyze its stock, the company's shares ...
The New York State Common Retirement Fund increases its holdings in Guardant Health, Inc. (NASDAQ:GH)
According to the most recent SEC filing that the company has made, during the third quarter of 2018, the New ...
Guardant Health, Inc. is purchased by Manufacturers Life Insurance Company for $7,593 shares (NASDAQ:GH)
According to the most recent report that Manufacturers Life Insurance Company submitted to the Securities and Exchange Commission (SEC), during ...
Shares of Guardant Health, Inc. (NASDAQ:GH) Prospera Financial Services Inc purchased
Prospera Financial Services Inc. increased its position in Guardant Health, Inc. (NASDAQ: GH) during the third quarter by a factor ...
Scotiabank Has Started Coverage of Guardant Health (NASDAQ:GH)
According to The Fly, equity analysts working for Scotiabank have reportedly assumed coverage on shares of Guardant Health (NASDAQ: G.H.) ...
The stock price of Guardant Health (NASDAQ:GH) has risen 3.2% as a result of an analyst upgrade.
The price target that Bank of America has set for Guardant Health, Inc. (NASDAQ: GH) has been raised from $65.00 ...
Guardant Health (NASDAQ:GH) PT has been reduced to $70.00.
The price objective that Cowen's equity research analysts have set for Guardant Health (NASDAQ: GH) dropped from $83.00 to $70.00 ...